Search research articles
Contact Us
Filters
Showing results (41-50 of 107) with videos related to
Page
of 11
Sort By:
British Journal of Haematology
|
August 18, 2018
Bendamustine and rituximab in elderly patients with low-tumour burden follicular lymphoma. Results of the LYSA phase II BRIEF study
Emmanuel Gyan, Anne Sonet, Pauline Brice, et al.
Blood
|
February 14, 2018
Early-onset invasive aspergillosis and other fungal infections in patients treated with ibrutinib
David Ghez, Anne Calleja, Caroline Protin, et al.
Ejhaem
|
February 26, 2024
Real-life effectiveness of carfilzomib in patients with relapsed multiple myeloma receiving treatment in the context of early access: The CARMYN study
Kamel Laribi, Xavier Leleu, Nathalie Texier, et al.
European Journal of Haematology
|
September 16, 2018
Inflammatory disorders associated with trisomy 8-myelodysplastic syndromes: French retrospective case-control study
Nadege Wesner, Louis Drevon, Alexis Guedon, et al.
Blood
|
April 20, 2016
Randomized phase 2 study: elotuzumab plus bortezomib/dexamethasone vs bortezomib/dexamethasone for relapsed/refractory MM
Andrzej Jakubowiak, Massimo Offidani, Brigitte Pégourie, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 5, 2025
Waldenström's macroglobulinemia: The LYSA pragmatic guidelines
Damien Roos-Weil, Cécile Tomowiak, Stéphanie Poulain, et al.
Kidney International Reports
|
December 18, 2023
Chronic Myelomonocytic Leukemia Patients With Lysozyme Nephropathy and Renal Infiltration Display Markers of Severe Disease
Marie-Camille Lafargue, Mickaël Bobot, Helmut G Rennke, et al.
Leukemia & Lymphoma
|
November 21, 2018
Gastrointestinal Behcet's-like disease with myelodysplastic neoplasms with trisomy 8: a French case series and literature review
Nadege Wesner, Louis Drevon, Alexis Guedon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 8, 2025
Brentuximab Vedotin Combination for Relapsed Diffuse Large B-Cell Lymphoma
Nancy L Bartlett, Uwe Hahn, Won-Seog Kim, et al.
The Lancet. Haematology
|
November 26, 2020
Bortezomib, thalidomide, and dexamethasone with or without daratumumab for transplantation-eligible patients with newly diagnosed multiple myeloma (CASSIOPEIA): health-related quality of life outcomes of a randomised, open-label, phase 3 trial
Murielle Roussel, Philippe Moreau, Benjamin Hebraud, et al.
Page
of 11
Search research articles
Search
Showing results (41-50 of 107) with videos related to
Sort By:
Page
of 11
British Journal of Haematology
|
August 18, 2018
Bendamustine and rituximab in elderly patients with low-tumour burden follicular lymphoma. Results of the LYSA phase II BRIEF study
Emmanuel Gyan, Anne Sonet, Pauline Brice, et al.
Blood
|
February 14, 2018
Early-onset invasive aspergillosis and other fungal infections in patients treated with ibrutinib
David Ghez, Anne Calleja, Caroline Protin, et al.
Ejhaem
|
February 26, 2024
Real-life effectiveness of carfilzomib in patients with relapsed multiple myeloma receiving treatment in the context of early access: The CARMYN study
Kamel Laribi, Xavier Leleu, Nathalie Texier, et al.
European Journal of Haematology
|
September 16, 2018
Inflammatory disorders associated with trisomy 8-myelodysplastic syndromes: French retrospective case-control study
Nadege Wesner, Louis Drevon, Alexis Guedon, et al.
Blood
|
April 20, 2016
Randomized phase 2 study: elotuzumab plus bortezomib/dexamethasone vs bortezomib/dexamethasone for relapsed/refractory MM
Andrzej Jakubowiak, Massimo Offidani, Brigitte Pégourie, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 5, 2025
Waldenström's macroglobulinemia: The LYSA pragmatic guidelines
Damien Roos-Weil, Cécile Tomowiak, Stéphanie Poulain, et al.
Kidney International Reports
|
December 18, 2023
Chronic Myelomonocytic Leukemia Patients With Lysozyme Nephropathy and Renal Infiltration Display Markers of Severe Disease
Marie-Camille Lafargue, Mickaël Bobot, Helmut G Rennke, et al.
Leukemia & Lymphoma
|
November 21, 2018
Gastrointestinal Behcet's-like disease with myelodysplastic neoplasms with trisomy 8: a French case series and literature review
Nadege Wesner, Louis Drevon, Alexis Guedon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 8, 2025
Brentuximab Vedotin Combination for Relapsed Diffuse Large B-Cell Lymphoma
Nancy L Bartlett, Uwe Hahn, Won-Seog Kim, et al.
The Lancet. Haematology
|
November 26, 2020
Bortezomib, thalidomide, and dexamethasone with or without daratumumab for transplantation-eligible patients with newly diagnosed multiple myeloma (CASSIOPEIA): health-related quality of life outcomes of a randomised, open-label, phase 3 trial
Murielle Roussel, Philippe Moreau, Benjamin Hebraud, et al.
Page
of 11